NSE has notified the suspension of trading in 9 units of UTI Mutual Fund’s UTI Fixed Term Income Fund (FTIF) Series XXXV-I (1260 Days) effective April 24, 2026. The suspension is triggered by the maturity redemption of the scheme, in accordance with Regulation 3.1.2 of the NSE Capital Market Trading Regulations Part A.

Key Points

• 9 UTI FTIF Series XXXV-I (1260 Day) scheme variants are suspended from trading effective April 24, 2026
• Suspension reason: Maturity redemption of the fixed-term scheme
• Trading in all affected units ceased from the closing hours of April 23, 2026
• Circular issued under Regulation 3.1.2 of NSE (Capital Market) Trading Regulations Part A
• All affected securities trade under the MF series on NSE

Regulatory Changes

No new regulatory changes introduced. The suspension is a standard procedural action under existing NSE Capital Market Trading Regulations (Regulation 3.1.2) upon maturity of a fixed-term mutual fund scheme.

Compliance Requirements

• Members are notified not to execute trades in the listed securities from the suspension date onward
• No further action required from members beyond acknowledging the suspension

Important Dates

• Last Trading Day: April 23, 2026 (closing hours)
• Suspension Effective Date: April 24, 2026

Impact Assessment

The impact is limited and routine. All 9 affected securities are variants (Direct/Regular plans with different payout options — QIDCWPO, AIDCWPO, FIDCWPO, MIDCWPO, Growth) of a single closed-ended UTI FTIF scheme that has reached its 1260-day maturity. Investors will receive redemption proceeds as per the scheme terms. There is no broader market impact as these are fixed-maturity plan units with a predetermined lifecycle.